Please enable JavaScript in your web browser settings, under the site permissions section to unlock full site functionality. Click here for help.

Article Image - OPKO Health Acquires EirGen Pharma

Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Scroll to keep reading

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy

You Might Also Like

Why Every Event Planner Needs a Venue Management Platform

24/02/2022Why Every Event Planner Needs a Venue Management Platform

Event planners need to use venue management platforms if they want their events to run as smoothly and successfully as possible. With the best venue management software, every element of an event lifecycle is covered, from registration and payment to reports a

Successful Consumer Analytics Equals Successful Digital Marketing

27/03/2023Successful Consumer Analytics Equals Successful Digital Marketing

It’s an exciting time to be a marketer, but it’s also a challenging time in the industry. Knowing what mediums to focus on and where to spend your marketing budget is no simple task.

Success in the Mining Market

29/07/2020Success in the Mining Market

Making a name for yourself in the world of business is no mean feat, especially if you’re a woman. With institutional biases and societal norms stacked against them, achieving success is something to be celebrated. Anna Stylianides is one of these names, ear

8 Tips For a Budget-Savvy Office Redesign

01/07/20228 Tips For a Budget-Savvy Office Redesign

The office space motivates team members to deliver their best during the workday if the design inspires them. If the office seems dull and dreary, the workers might be too. Realizing the office needs a change is the first step to a beautiful redesign.

GLOBALFOUNDRIES Acquires IBM’s Microelectronics

15/12/2014GLOBALFOUNDRIES Acquires IBM’s Microelectronics

We spoke to Marco Chisari, Head of Corporate Development and M&A at GLOBALFOUNDRIES, to find out more about the deal

Why Do Students Pay for Essays?

11/01/2023Why Do Students Pay for Essays?

In the Western educational system, including universities in the United States, essays are considered to be one of the most common types of written assignments. Such papers teach high school students to reason, draw conclusions, and make their points of view.

How This Business Uses AI to Understand Its Customer Base

07/11/2023How This Business Uses AI to Understand Its Customer Base

According to Forbes, more than nine in ten (97%) business owners believe ChatGPT will help their business.

Should You Focus on LinkedIn or Facebook When Growing a B2B Business?

21/04/2022Should You Focus on LinkedIn or Facebook When Growing a B2B Business?

Should You Focus on LinkedIn or Facebook When Growing a B2B Business? Facebook and LinkedIn are great platforms for your business. However, they aren’t the same. Facebook is great for brands that are trying to reach their customers directly. It earns you a l

Direct Selling: Breaking Down Barriers for Female Entrepreneurs

08/03/2023Direct Selling: Breaking Down Barriers for Female Entrepreneurs

The number of women determining their own success by becoming their own bosses has increased over the last decade with an estimated 252 million females running their own businesses[1]. With this number continuing to climb, it’s clear that more women than eve

View More Articles

Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

MORE BRANDS